Icad Reports Positive Study Results

Icad Reports Positive Study Results

Icad developer of cancer treatments, Wednesday reported positive results of a matched-pair cohort study of 369 early-stage non-melanoma skin cancer patients treated with the company’s Xoft Axxent electronic brachytherapy system (x-rays applied to skin cancer sites) or the Mohs micrographic surgery. The study found that rates of recurrence of cancer were virtually identical. The study results were published online in the peer-reviewed Journal of Contemporary Brachytherapy. Icad said Mohs micrographic […]

Read More ˃